Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene vs letrozole vs gonadotropin for ovulation induction in infertile women with polycystic ovary syndrome
IRCT20120215009014N417Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of clomiphene and letrozole in polycystic ovary syndrome (PCOS) and female infertility (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Dominant follicle formation and Chemical pregnancy. Started Apr 2022; status: completed.
02
Drugs
clomipheneletrozole
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20120215009014N417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N417.